Alfa Laval is expanding its range of UltraPure pharmaceutical pumps with even more selection. Whether a pharmaceutical or biotech process requires a centrifugal or PD (positive displacement) pump, the complete range of Alfa Laval UltraPure pumps cover virtually any pharma or biotech need. “These are safe and reliable pumps, with features such as hygienic design, repeatability and minimized contamination risk,” says Alfa Laval UltraPure Portfolio Manager John Walker. “Along with higher yields, increased uptime and the low energy consumption, this translates into lower user costs. As sustainability aspects continue to gain traction in the market, the pharma and biotech industry will appreciate the energy efficiency and low CO2 footprint.”
The expanded range includes the newly released
- LKH Prime UltraPure,
- a greater selection of the LKH UltraPure,
- the new SX UltraPure and
- the streamlined high-performance Solid-C UltraPure.
The LKH Prime UltraPure is a self-priming pharmaceutical pump. Primarily used for CIP duties containing entrained air, the LKH Prime UltraPure can also pump product.
The LKH UltraPure delivers maximum uptime and high efficiency for pharmaceutical applications. A precision-engineered pump and motor provide optimal efficiency with gentle product treatment.
The new SX UltraPure offers low pulsation and gentle pumping, and is designed specifically for transporting sensitive liquids efficiently and effectively. It is made for the hygienic and high-purity applications of the biotechnology and pharmaceutical industries.
The Solid C UltraPure is a standardized centrifugal pump for use in duties such as CIP and intermittent product pumping.